To amend the Public Health Service Act to require group and individual health insurance coverage and group health plans to provide for cost sharing for oral anticancer drugs on terms no less favorable than the cost sharing provided for anticancer medications administered by a health care provider.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Representative for New Jersey's 7th congressional district. Republican.
Last Updated: Mar 7, 2017
Length: 5 pages
115th Congress (2017–2019)
This bill was introduced on March 7, 2017, in a previous session of Congress, but it did not receive a vote.
Although this bill was not enacted, its provisions could have become law by being included in another bill. It is common for legislative text to be introduced concurrently in multiple bills (called companion bills), re-introduced in subsequent sessions of Congress in new bills, or added to larger bills (sometimes called omnibus bills).
175 Cosponsors (90 Democrats, 85 Republicans)
What legislators are saying
“Lance Bill Confronts Health Care Costs”
— Rep. Leonard Lance [R-NJ7, 2009-2018] (Sponsor) on Mar 29, 2017
“What They Are Saying: Cancer Drug Parity Act”
— Sen. Jerry Moran [R-KS] on Dec 14, 2018
More statements at ProPublica Represent...
What stakeholders are saying
Mar 7, 2017
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
H.R. 1409 (115th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
Bills numbers restart every two years. That means there are other bills with the number H.R. 1409. This is the one from the 115th Congress.
This bill was introduced in the 115th Congress, which met from Jan 3, 2017 to Jan 3, 2019. Legislation not passed by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2023). H.R. 1409 — 115th Congress: Cancer Drug Parity Act of 2017. Retrieved from https://www.govtrack.us/congress/bills/115/hr1409
“H.R. 1409 — 115th Congress: Cancer Drug Parity Act of 2017.” www.GovTrack.us. 2017. March 22, 2023 <https://www.govtrack.us/congress/bills/115/hr1409>
Cancer Drug Parity Act of 2017, H.R. 1409, 115th Cong..
|title=H.R. 1409 (115th)
|accessdate=March 22, 2023
|author=115th Congress (2017)
|date=March 7, 2017
|quote=Cancer Drug Parity Act of 2017
- show another citation format:
- Blue Book
- Wikipedia Template
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.